Why PBMs were completely spared in the IRA while the people who actually make drugs got hit with unprecedented government price setting
New scrutiny that PBMs now face scrutiny on the Hill, including Prescription Pricing for the People Act (S. 113) and the PBM Transparency Act (S. 127) with new bills and “noisy” hearings